Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease

The composition of the gut microbiome is altered in patients with chronic kidney disease (CKD). Dysbiosis leads to decreased levels of stool organic acids (OAs) and systemic inflammation, followed by accumulation of uremic toxins (UTs) and the development of end-stage kidney disease (ESKD). We asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshida, Takeo, Gohda, Tomohito, Sugimoto, Takuya, Asahara, Takashi, Asao, Rin, Ohsawa, Isao, Gotoh, Hiromichi, Murakoshi, Maki, Suzuki, Yusuke, Yamashiro, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380578/
https://www.ncbi.nlm.nih.gov/pubmed/37511232
http://dx.doi.org/10.3390/ijms241411456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380578/
https://www.ncbi.nlm.nih.gov/pubmed/37511232
http://dx.doi.org/10.3390/ijms241411456

Ejemplares similares